Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Breast Neoplasms 4Neoplasms 3Anxiety Disorders 3Motor Activity 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Vomiting 1Triple Negative Breast Neoplasms 1Treatment Adherence and Compliance 1Sclerosteosis 1Recurrence 1Periodontitis 1Periodontal Diseases 1Patient Compliance 1Osteoporosis, Postmenopausal 1Obesity 1Nausea 1Lymphedema 1Liver Cirrhosis 1Leukemia, Promyelocytic, Acute 1Inflammation 1Gastrointestinal Neoplasms 1Feeding Behavior 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Rituximab 259Cyclophosphamide 238Etoposide 114Prednisone 97Vincristine 96Doxorubicin 96Peripheral Blood Stem Cell Transplantation 95fludarabine phosphate 87Filgrastim 80Cytarabine 61Lenalidomide 60Mycophenolic Acid 59Melphalan 59Radiotherapy 58Busulfan 52Cyclosporine 50Carmustine 49Whole-Body Irradiation 48Tacrolimus 46Methotrexate 42Antilymphocyte Serum 38Gemcitabine 33Ifosfamide 32Carboplatin 32fludarabine 31Dexamethasone 31polatuzumab vedotin 29Granulocyte Colony-Stimulating Factor 29CT-P10 28Methylprednisolone 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Large B-Cell, Diffuse × Weights and Measures × Clear all
NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

H. Lee Moffitt Cancer Center and Research Institute

Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04113226 2023-02-08

Relyage

Centre Hospitalier Universitaire, Amiens

Phase 2 Unknown
114 enrolled
LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡